TOP NEWS: Glaxo Says US Panel Voted Against Mepolizumab For COPD
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday an advisory panel of US Food & Drug Administration has recommended against approval of mepolizumab for the treatment of chronic a of Read More